Abstract
Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.
MeSH terms
-
Diabetes Mellitus, Type 2* / complications
-
Diabetes Mellitus, Type 2* / drug therapy
-
Humans
-
Kidney
-
Naphthyridines / adverse effects
-
Renal Insufficiency, Chronic* / complications
-
Renal Insufficiency, Chronic* / drug therapy
Substances
-
Naphthyridines
-
finerenone